Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Urology, Nephrology and Andrology International

Volume  5, Issue 1, January-June 2020, Pages 21-23
 

Original Article

Is Re TURBT Clinically Significant in Non Muscle Invasive Bladder Cancer?

Prakash Hebbulse Shivalingaiah, Mahantesh G Todkar, Trissia Mary George

1Associate Professor and Head, 3Post Graduate Resident, Department of General Surgery, Department of Urology, Krishna Rajendra Hospital, Mysore Medical College and Research Institute, Mysore, Karnataka 570001, India. 2Assistant Professor, Belagavi Institute of Medical Sciences, Belagavi, Karnataka 590019, India.

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: http://dx.doi.org/10.21088/unai.2456-5016.5120.4

Abstract

Aim: The aim of the study was to define the utility of restage TURBT and to evaluate the impact of restage TURBT on the incidence of tumour recurrence and progression in patients with non-muscle invasive bladder cancer. Materials and Methods: A prospective observational study was performed with an aim of analyzing the utility of restage TURBT at a tertiary care centre during July 2018-December 2019. Patients enrolled for restage TURBT were proven with histological diagnosis of non muscle invasive bladder cancer. All patients underwent restage TURBT within 4 to 6 weeks after the initial resection. Comparison of histological findings of initial TURBT and restage TURBT were done. Results:Total data available for 68 patients. Among them 27 patients (40%) were detected to have residual disease. Out of this in 11 patients (40%) high grade tumour residual disease was established and in 14 patients (52%) low grade tumour residual disease was established .Two patients (8%) were detected to have muscle invasive bladder cancer after restage TURBT. Conclusion:The study concluded that the restage TURBT is of clinical significance in non-muscle invasive bladder cancer as it helps in early detection, treatment and prognosis in cases of advanced bladder cancer.

Keywords: Restage TURBT; NMIBC; Residual bladder tumour.
 


Corresponding Author : Trissia Mary George